牙周基础治疗对脑卒中高危人群伴中重度牙周炎患者血清sCD40L及牙周临床指标的影响被引量：12

Effects of essential periodontal treatment on serum level of s CD40L and periodontal clinical parameters in patients with moderate to severe periodontitis at high risk of stroke

原文传递

导出

摘要目的:观察脑卒中高危人群伴中重度牙周炎患者治疗前、后血清可溶性白细胞分化抗原配体(soluble CD40ligand,sCD40L)水平的变化,探讨牙周基础治疗对脑卒中高危人群伴中重度牙周炎患者的影响。方法:收集脑卒中高危人群伴中重度牙周炎患者76例,随机分为2组。A组40例,接受牙周基础治疗+相应的常规维持治疗;B组36例,仅接受常规维持治疗。另选取单纯中重度牙周炎患者36例,设为C组,接受牙周基础治疗。分别在治疗前和治疗后3个月由同一名口腔医师检查全口牙6个位点的探诊出血(bleeding on probing,BOP)、牙周探诊深度(probing depth,PD)、附着丧失(attachment loss,AL),用酶联免疫吸附反应法(ELISA)检测血清sCD40L水平。采用SPSS17.0软件包对数据进行统计学分析。结果:与治疗前相比,3组患者血清sCD40L水平及牙周临床指标均下降;与B组相比,A组下降更加明显,具有显著差异(P<0.05)。结论:牙周基础治疗能降低脑卒中高危人群伴中重度牙周炎患者血清sCD40L水平,改善机体的炎症状态,在一定程度上降低脑卒中高危人群向脑卒中发展的风险。 PURPOSE： To investigate the effect of periodontal treatment on patients with moderate to severe periodontitis at high risk of stroke, by detecting the level of serum soluble cell differentiation antigen 40 ligand （sCD40L） before and after periodontal non-surgical treatment. METHODS： Seventy-six patients with moderate to severe periodontitis at high risk of stroke were collected and randomly divided into 2 groups, 40 patients in group A received essential periodontal treatment ＋ routine maintenance therapy, 36 cases in group B only received routine maintenance therapy. Another 36 patients with moderate and severe periodontitis were selected as group C, and received essential periodontal treatment. Bleeding on probing （BOP）, periodontal probing depth （PD） and attachment loss （AL） in 6 loci were examined by the same dentists, and enzyme linked immunosorbent assay （ELISA） was used to detect the level of serum sCD40L before treatment and 3 months after treatment. The data were analyzed by SPSS 17.0 software package. RESULTS： Compared with pre-treatment, serum level of sCD40L and periodontal clinical indexes of the three groups decreased. Compared with group B, serum SCD40L in group A significantly decreased（P〈0.05）. CONCLUSIONS： Periodontal treatment can reduce the serum level of sCD40L in patients with moderate to severe periodontitis at high risk of stroke, and improve the patient＇s inflammatory state. To a certain extent, periodontal treatment may reduce the risk of high-risk stroke population to develop stroke.

作者高磊孙晓菊谢洪南顺花谢慧心

机构地区大连医科大学辽宁省人民医院口腔科齐齐哈尔医学院附属第三医院口腔科中国医科大学口腔医学院

出处《上海口腔医学》 CAS CSCD 2016年第5期574-578,共5页 Shanghai Journal of Stomatology

基金辽宁省科学事业公益研究基金(201507) 沈阳市科技计划项目(F14-158-9-04)

关键词牙周基础治疗脑卒中高危人群中重度牙周炎 SCD40L 牙周临床指标 Essential periodontal treatment Patients with high risk of stroke Moderate to severe periodontitis sCD40ligand （sCD40L） Periodontal clinical parameters

分类号 R781.4 [医药卫生—口腔医学]

引文网络
相关文献

参考文献26

1孟焕新,主编.牙周病学[M].第4版,北京:人民卫生出版社,2012.127-153.
2陈红岩,孙晓菊,谢洪,陈晓虹,张喆.慢性牙周炎与脑血栓形成相关性研究[J].中国实用口腔科杂志,2010,3(3):164-166. 被引量：11
3Page RC, Kornman KS. The pathogenesis of human periodontitis: an introduction [J]. Periodontol 2000, 1997, 14:9-11.
4Teng YT. The role of acquired immunity and periodontal disease progression [J]. Crit Rev Oral Biol Med, 2003, 14(4): 237-252.
5Yamazaki K, Yoshie H, Seymour GJ. T cell regulation of the immune response to infection in periodontal diseases [J]. Histol Histopathol, 2003, 18(3): 889-896.
6Mathur A, Michalowicz BS. Cell-mediated immune system regulation in periodontal diseases [J]. Crit Rev Oral Biol Med, 1997, 8(1): 76-89.
7Chaturvedi R, Gupta M, Jain A, et al. Soluble CD40 ligand: a novel hiomarker in the pathogenesis of periodontal disease[J]. Clin Oral Investig, 2015, 19(1): 45-52.
8Schonbeck U, Mach F, Libby P. CD154 (CD 40 ligand )[J]. Int J Biochem Cell Biol, 2000, 32(30): 687-693.
9Freedman JE. CD40-CD40L and platelet function: beyond hemostasis [J]. Circ Res, 2003, 92(9): 944-946.
10Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells [J]. Nature, 1998, 391(6667): 591-594.

二级参考文献53

1闫士广,李德香,李学松,王顶秀,蒋建章.牙周炎合并脑梗塞的临床研究[J].中华医学写作杂志,2001,8(12):1347-1349. 被引量：1
2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量：5230
3王建军,邹丽萍,石凯丽,李久伟,蒋丽琼,吴沪生,方方,丁昌红,肖静,吕俊兰.北京市儿童医院10年儿童脑卒中疾病谱回顾性分析[J].中国循证儿科杂志,2007,2(4):259-264. 被引量：13
4Hansson GK. |nfammation, Atherosclerosis and coronary artery disease. N EnglJ Med,2005,352(20):1 685-1 695.
5Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory teaction of endothelial cells. Nature,1998,391(2):591-594.
6Andre P, Prasad KS, Denis CV, et al. CDL stabilizes arterial thrombi by a 133 integrin-dependent mechanism. Nat Med, 2002, 8(3):247-252.
7Grewal IS, Flavell RA. CD40 ligand. Immunol Res, 1997, 16(1):59-70.
8Schonbeck U, Libby P. CD40 signaling and plaque instability. Circ Res,2001,89(12) :1 092-1 103.
9Phipps RP. Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. Proe Nail Acad Sci USA, 2000,97(13) :6 930-6 932.
10Sangnigni V, Ferro D, Pignatelli P,et al. CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia. J Am Coll Cardiol,2005,45(1) :35-42.